Conversations | AuntMinnie

AI diagnostic aid helps novice MRI readers, but experts not so much

By Kate Madden Yee

The findings point to where AI decision support delivers the most clinical value.

May 26, 2026

American Board of Magnetic Resonance Safety rebrands with new name

By AuntMinnie.com staff writers

The ABMRS has changed its name to reflect the board's expanded global role in MR safety certification.

May 26, 2026

Mr Scanner 400 (2)

Hyperfine to join Russell 3000, Russell 2000 indexes in June

By AuntMinnie.com staff writers

Hyperfine is expected to join the Russell 3000 and Russell 2000 indexes in June.

May 26, 2026

Business Costs Rising Arrow Up 400

Multimodal brain health composites outperform standard AD biomarkers

By Kate Madden Yee

"Reproducible, multimodal composites can capture distinct yet complementary dimensions of brain health," researchers noted.

May 22, 2026

MRI-specific AI algorithm reads cardiac scans with up to 99% accuracy

By Kate Madden Yee

The algorithm beat existing general-purpose AI models by up to 35%, researchers reported.

May 21, 2026

Cardiac Mri Adobe Samunella

DeepHealth secures FDA clearance, CE marking for neuro, prostate AI

By AuntMinnie.com staff writers

The company has won multiple regulatory clearances for neuro, prostate, and lumbar MRI AI.

May 20, 2026

MRI-based ML model shows promise in colorectal cancer subtyping

By Amerigo Allegretto

A machine-learning model based on MRI radiomics achieved high performance in predicting colorectal cancer subtypes.

May 19, 2026

Overview of the study design, including data collection, radiomics model construction, and biologic interpretation. (A) The primary cohort for model development and evaluation in the training and internal test sets includes 168 patients with colorectal cancer (CRC) from center 1 (Fudan University Shanghai Cancer Center), whereas external testing was performed using data from 85 patients from centers 2 (Huashan Hospital, Fudan University) and 3 (Zhongshan Hospital, Fudan University). For model interpretation, RNA sequencing (RNA-seq) data from 18 patients with CRC in center 1 and single-cell data from 35 patients from the Gene Expression Omnibus (GEO) database are incorporated. Mismatch repair (MMR) protein expression, obtained from pathologic reports in electronic medical records (EMRs), was used to identify patients with consensus molecular subtype 1 (CMS1) CRC. Tissue microarrays (TMAs) from surgically obtained CRC tissues were analyzed for immunohistochemical staining of caudal-type homeobox 2 (CDX2), 5-hydroxytryptamine receptor 2B (HTR2B), FERM domain containing 6 (FRMD6), and zinc finger E-box binding homeobox 1 (ZEB1), and the results were subsequently entered into an online classification tool that assigned patients to CMS2, 3, or 4 subtypes. (B) Radiomics workflow for CMS4 prediction. Lesions were manually delineated on T2-weighted imaging (T2WI) and contrast-enhanced (CE) T1-weighted imaging (T1WI), followed by radiomics feature extraction. Feature selection and model development were performed in the training set using machine-learning algorithms with fivefold cross-validation for model selection, and the final model was evaluated in the internal and external test sets using receiver operating characteristic (ROC) curve analysis. (C) Transcriptomic interpretation workflow. Using the radiomics-predicted CMS4 classification, bulk RNA sequencing (RNA-seq) data were used to perform differential expression analysis between predicted CMS4 and non-CMS4 groups, followed by pathway enrichment analyses to assess biologic relevance. Public single-cell RNA sequencing data from the Gene Expression Omnibus database were then used for cell-type–level interrogation to support interpretation of the associated pathways.

Podcast: Expert witness hats come out to begin closing investigation

The episode the hosts have eagerly anticipated.

May 19, 2026

The Invisible Force Podcast Album Cover Auntminnie Jan 2026 Thumbnail sra O0 D Ij Z6

Cochrane updates 2013 prostate cancer screening review

By Kate Madden Yee

Standard PSA screening has a well-known weakness: it catches many slow-growing cancers that would never have caused harm, Cochrane said.

May 18, 2026

SimonMed launches discounted whole-body MRI for veterans

By AuntMinnie.com staff writers

SimonMed is launching an initiative offering military personnel, veterans, and first responders 20% off whole-body MRI screening.

May 18, 2026

ISMRM: fMRI flags brain network failures in fibromyalgia, long COVID

By Kate Madden Yee

While both conditions demonstrate reduced brain network flexibility, the underlying mechanisms differ.

May 18, 2026

Muscle Trigger Points Sized

ISMRM: Researchers eye fibrosis patterns in the body's organs

Quantitative measures obtained from MRIs enable fibrotic scoring system, according to group.

May 15, 2026

Fibrotic Buckets Disease Inclusion Uk Biobank Population Ismrm2026

Page 1 of 644